A Phase II Trial of Chemotherapy followed by Response-Based Whole Ventricular Spinal Canal Irradiation WVSCI for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy HIPEC with Cisplatin versus no HIPEC at the Time of Interval Cytoreductive Surgery followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Hyperthermia Ovarian Treatment Trial
A Phase IIA, Open-label, Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of BP1001 a Liposomal Grb2 Antisense Oligonucleotide in Combination with Venetoclax plus Decitabine in Patients with Acute Myeloid Leukemia AML Who Are Ineligible for Intensive Induction Therapy
PD-Inhibitor Nivolumab and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
A Phase I Study of RGX-104, a Small Molecule LXR Agonist, as a Single Agent and as Combination Therapy in Patients with Advanced Solid Malignancies and Lymphoma with an Expansion in Select Malignancies
A Phase I Study of Patient-Derived Multi-Tumor-Associated Antigen-Specific T-Cells MT-601 Administered to Patients with Relapsed or refractory Non-Hodgkin Lymphoma NHL [APOLLO]
Pivotal, Randomized, Open-Label Study of Tumor Treating Fields
Ttfields Concurrent with Standard of Care Therapies for Treatment of Stage 4
Non-Small Cell Lung Cancer NSCLC Following Platinum Failure
A Phase IB, Open-Label, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of UTTR1147A in Combination with Standard of Care in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation